Navigation Links
Aware, Inc. Reports First Quarter 2009 Financial Results

BEDFORD, Mass., May 5 /PRNewswire-FirstCall/ -- Aware, Inc. (Nasdaq: AWRE), a leading supplier of broadband technology and biometrics software, today reported financial results for its first quarter ended March 31, 2009.

Revenues for the first quarter of 2009 were $4.6 million, a decrease of 22% compared to $5.9 million in the same quarter last year.

The Company reports its net income and basic and diluted net income per share in accordance with U.S. generally accepted accounting principles (GAAP), and additionally, on a non-GAAP basis. Non-GAAP net income, where applicable, excludes the effect of stock-based compensation expense. The company uses the non-GAAP information internally to evaluate its operating performance and believes these non-GAAP measures are useful to investors as they provide additional insight into the underlying operating results. However, non-GAAP measures are not stated in accordance with, should not be considered in isolation from, and are not a substitute for, GAAP measures. A reconciliation of GAAP to non-GAAP results has been provided in the attached financial tables.

The GAAP net loss for the first quarter of 2009 was $2.1 million, or $0.09 per diluted share, which included $0.4 million of stock-based compensation charges in accordance with the provisions of FAS 123(R). This compared to a GAAP net loss of $1.3 million, or $0.05 per diluted share, for the same period a year ago.

The non-GAAP net loss for the first quarter of 2009, excluding the effect of stock-based compensation, was $1.7 million, or $0.07 per diluted share.

Michael Tzannes, Aware's chief executive officer, said, "We continued to experience slowdowns in our business as a result of the slowing economy during the first quarter. Our goal is to emerge from the current environment stronger and focused on growth in our target markets. We believe we will succeed by focusing on leading edge, innovative solutions to a large and diverse customer base in the biometrics and broadband markets."

Note: Aware's conference call will be broadcast live over the Internet today, May 5, 2009 at 5:00 p.m. Eastern Time. To listen to the call, please go to The conference call may also be heard by calling 719-325-4808 and referencing the confirmation number 1841428. A replay of the call will be archived on our website after the call.

About Aware

Aware is a leading technology and software supplier for the telecommunications and biometrics industries. For more than ten years, Aware has pioneered innovations at telecommunications standards-setting organizations and continues to develop and market DSL silicon intellectual property and test and diagnostics products. Its StratiPHY(tm) IP product line supports DSL standards, including ADSL2+ and VDSL2, and has been broadly licensed to leading semiconductor companies. Telecom equipment vendors and phone companies use Aware's DSL test and diagnostics modules and Dr. DSL(R) software to help provision DSL circuits globally. Aware is also a veteran of the biometrics industry, providing biometric and imaging software components used in government systems worldwide since 1992. Aware's interoperable, standard-compliant, field-proven imaging products are used in a number of applications, from border management to criminal justice to medical imaging. Aware is a publicly held company (Nasdaq: AWRE) based in Bedford, Massachusetts.

Safe Harbor Warning

Portions of this release contain forward-looking statements regarding future events and are subject to risks and uncertainties, such as estimates or projections of future revenue and earnings and the growth of the DSL and biometrics markets. Aware wishes to caution you that there are factors that could cause actual results to differ materially from the results indicated by such statements. General factors include, but are not limited to: our quarterly results are unpredictable and may fluctuate significantly; our business is subject to rapid technological change; we face intense competition from a wide range of competitors; current economic conditions, including the credit crisis affecting the financial markets; our intellectual property is subject to limited protection; our ability to obtain or enforce patents could be affected by new laws, regulations or rules; and our business may be affected by government regulations. DSL factors include, but are not limited to: our DSL licensing and DSL test and diagnostic businesses depend upon a limited number of customers; there has been and may continue to be a cyclical demand for DSL chipsets; the success of our DSL licensing and test and diagnostics products businesses requires telephone companies to install DSL service in volume; our test and diagnostic hardware and software products could have quality problems; we depend on a single source contract manufacturer for the manufacture of our DSL hardware products; and we are dependent on single source suppliers for components in our DSL hardware products. Biometric factors include, but are not limited to: market acceptance of our biometric technologies and products; changes in contracting practices of government or law enforcement agencies; the failure of the biometrics market to experience continued growth; announcements or introductions of new technologies or products by our competitors; failures or problems in our biometric software products; delays in the adoption of new industry biometric standards; growth of proprietary biometric systems which do not conform to industry standards; our ability to sell services contracts in a manner that is consistent with our business model; our ability to deliver service contract milestones; and our dependence on third party contractors and consultants to deliver certain services contract milestones. We refer you to the documents Aware files from time to time with the Securities and Exchange Commission, specifically the section titled Risk Factors in our annual report on Form 10-K for the fiscal year ended December 31, 2008 and other reports and filings made with the Securities and Exchange Commission.

Aware, StratiPHY, and Dr. DSL are trademarks or registered trademarks of Aware, Inc.

                                     AWARE, INC.
                       (In thousands, except per share data)

                                              Three Months Ended
                                                   March 31,
                                             2009           2008
      Product sales                         $2,819          $3,924
      Contract revenue                       1,277           1,521
      Royalties                                477             431
        Total revenue                        4,573           5,876

    Costs and expenses:
      Cost of product sales (1)                513             824
      Cost of contract revenue (1)             908           1,018
      Research and development (1)           3,111           3,528
      Selling and marketing (1)              1,081             969
      General and administrative (1)         1,213           1,193
        Total costs and expenses             6,826           7,532

    Net loss from operations                (2,253)         (1,656)
    Interest income                            125             383

    Net loss before provision for
     income taxes                           (2,128)         (1,273)
    Provision for income taxes                   3               9

    Net loss                               ($2,131)        ($1,282)

    Net loss per share - basic              ($0.09)         ($0.05)
    Net loss per share - diluted            ($0.09)         ($0.05)

    Weighted average shares - basic     23,281,204      23,880,358
    Weighted average shares - diluted   23,281,204      23,880,358

    (1) Effective January 1, 2006 the Company adopted Statement of Financial
    Accounting Standard No. 123 (Revised), "Share-Based Payment" (FAS 123(R)).
    The amounts in the tables above include stock-based compensation as
    follows (in thousands):

                                              Three Months Ended
                                                   March 31,
                                             2009           2008
    Cost of product sales                     $3             $3
    Cost of contract revenue                  32             34
    Research and development                 146            167
    Sales and marketing                       52             31
    General and administrative               158             90
    Total stock-based compensation costs    $391           $325

                                    AWARE, INC.
                  Non-GAAP Financial Measures and Reconciliation
                      (In thousands, except per share data)

                                           Three Months Ended
                                               March 31,
                                          2009         2008
    GAAP net loss                        ($2,131)     ($1,282)
       Stock-based compensation              391          325
    Non-GAAP net loss                    ($1,740)       ($957)

                                           Three Months Ended
                                                March 31,
                                          2009         2008
    GAAP diluted net loss per share       ($0.09)      ($0.05)
       Stock-based compensation per share   0.02         0.01
    Non-GAAP diluted net loss per share   ($0.07)      ($0.04)

                                    AWARE, INC.
                                  (In thousands)

                                              March 31,     December 31,
                                                 2009             2008
         Cash and investments                  $42,513          $45,516
         Accounts receivable, net                3,426            2,211
         Inventories, net                        1,558            1,656
         Property and equipment, net             7,327            7,463
         Other assets, net                         977              700
         Total assets                          $55,801          $57,546

         Total current liabilities              $2,688           $2,693
         Long-term deferred revenue                330              330
         Total stockholders' equity             52,783           54,523
         Total liabilities and stockholders'
          equity                               $55,801          $57,546

SOURCE Aware, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology news :

1. Aware, Inc. Announces Final Results of Dutch Auction Tender Offer
2. Aware, Inc. Announces Q1 09 Earnings Conference Call
3. Aware, Inc. Amends and Extends Dutch Auction Tender Offer
4. Aware, Inc. Announces Preliminary Results of Dutch Auction Tender Offer
5. Aware, Inc. Amends and Extends Dutch Auction Tender Offer
6. Aware, Inc. Commences Dutch Auction Tender Offer
7. Aware, Inc. Commences Dutch Auction Tender Offer
8. Aware, Inc. Reports Fourth Quarter and 2008 Financial Results
9. Sun Microsystems and Aware, Inc. Announce Integration of Awares BioSP with Sun Identity Management Solutions
10. Aware, Inc. Reports Fourth Quarter and 2007 Financial Results
11. Aware, Inc. Announces Richard Moberg to Return as CFO
Post Your Comments:
(Date:4/11/2017)... Florida , April 11, 2017 ... a security technology company, announces the appointment of independent Directors ... Bendheim to its Board of Directors, furthering the company,s ... ... of NXT-ID, we look forward to their guidance and benefiting ...
(Date:4/5/2017)... , April 4, 2017 KEY FINDINGS ... to expand at a CAGR of 25.76% during the ... is the primary factor for the growth of the ... MARKET INSIGHTS The global stem ... technology, application, and geography. The stem cell market of ...
(Date:3/30/2017)... The research team of The Hong Kong ... identification by adopting ground breaking 3D fingerprint minutiae recovery and matching ... and accuracy for use in identification, crime investigation, immigration control, security ... ... A research team led by ...
Breaking Biology News(10 mins):
(Date:10/11/2017)... ... 11, 2017 , ... ComplianceOnline’s Medical Device Summit is back for its 4th ... in San Francisco, CA. The Summit brings together current and former FDA office bearers, ... and government officials from around the world to address key issues in device compliance, ...
(Date:10/11/2017)... , Oct. 11, 2017  VMS BioMarketing, a leading ... a nationwide oncology Clinical Nurse Educator (CNE) network, which will ... need for communication among health care professionals to enhance the ... nurses, office staff, and other health care professionals to help ... breast cancer. ...
(Date:10/11/2017)... Georgia (PRWEB) , ... October 11, 2017 , ... Disappearing ... taking the lives of over 5.5 million people each year. Especially those living in ... greenovative startup Treepex - based in one of the most pollution-affected countries globally - ...
(Date:10/11/2017)... Tampa Bay, Florida (PRWEB) , ... October 11, ... ... Food and Drug Administration (FDA) has granted orphan drug designation to SBT-100, its ... antibody (sdAb) for the treatment of osteosarcoma. SBT-100 is able to cross the ...
Breaking Biology Technology: